Viela Bio to Webcast Fourth Quarter and Full Year 2019 Operating and Financial Results on March 25, 2020

GAITHERSBURG, Md., March 18, 2020 (GLOBE NEWSWIRE) -- Viela Bio (Nasdaq:VIE), a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory disease, today announced it will host a webcast and conference call on Wednesday, March 25, 2020 at 5:00 p.m. ET to discuss its fourth quarter and full year 2019 operating and financial results.

The webcast will be accessible on the Events & Presentations page of the Company’s website.  Individuals can participate in the conference call by dialing [phone] (domestic) or [phone] (international) and referring to conference ID #: 5057166. The archived webcast will be available for replay on the Viela Bio website approximately two hours after the event.

About Viela Bio

Viela Bio, headquartered in Gaithersburg, Maryland, is a clinical-stage biotechnology company dedicated to the discovery, development and commercialization of novel treatments for autoimmune and severe inflammatory diseases. For more information, please visit www.vielabio.com.

Source: Viela Bio

CONTACT: Contacts:

Investors:
Solebury Trout
Chad Rubin
646-378-2947
[e-mail] 

Media:
Solebury Trout
Amy Bonanno
914-450-0349
[e-mail]